View in EDS PDF Full Text

Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib.

Saved in:
Bibliographic Details
Title: Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib.
Authors: Kappelman MD; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Long MD; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Zhang X; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lin FC; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Weisbein L; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Chen W; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Burris J; Yale School of Medicine, New Haven, Connecticut, USA., Dorand JE; Crohn's & Colitis Foundation, New York, New York, USA., Parlett LE; Healthcore, Wilmington, Delaware, USA., Fehlmann T; Crohn's & Colitis Foundation, New York, New York, USA., Brensinger CM; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Haynes K; Janssen Research & Development, Titusville, New Jersey, USA., Nair V; Humana, Lexington, Kentucky, USA., Kaul AF; Medical Outcomes Management and the Practice Research Network (PRACnet), Sharon, Massachusetts, USA., Dobes A; Crohn's & Colitis Foundation, New York, New York, USA., Lewis JD; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Source: Crohn's & colitis 360 [Crohns Colitis 360] 2023 May 29; Vol. 5 (3), pp. otad031. Date of Electronic Publication: 2023 May 29 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101752188 Publication Model: eCollection Cited Medium: Internet ISSN: 2631-827X (Electronic) Linking ISSN: 2631827X NLM ISO Abbreviation: Crohns Colitis 360 Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37350775
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kappelman+MD%22">Kappelman MD</searchLink>; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Long+MD%22">Long MD</searchLink>; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Lin+FC%22">Lin FC</searchLink>; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Weisbein+L%22">Weisbein L</searchLink>; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Burris+J%22">Burris J</searchLink>; Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Dorand+JE%22">Dorand JE</searchLink>; Crohn's & Colitis Foundation, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Parlett+LE%22">Parlett LE</searchLink>; Healthcore, Wilmington, Delaware, USA.<br /><searchLink fieldCode="AU" term="%22Fehlmann+T%22">Fehlmann T</searchLink>; Crohn's & Colitis Foundation, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Brensinger+CM%22">Brensinger CM</searchLink>; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Haynes+K%22">Haynes K</searchLink>; Janssen Research & Development, Titusville, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Nair+V%22">Nair V</searchLink>; Humana, Lexington, Kentucky, USA.<br /><searchLink fieldCode="AU" term="%22Kaul+AF%22">Kaul AF</searchLink>; Medical Outcomes Management and the Practice Research Network (PRACnet), Sharon, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Dobes+A%22">Dobes A</searchLink>; Crohn's & Colitis Foundation, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Lewis+JD%22">Lewis JD</searchLink>; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101752188%22">Crohn's & colitis 360</searchLink> [Crohns Colitis 360] 2023 May 29; Vol. 5 (3), pp. otad031. <i>Date of Electronic Publication: </i>2023 May 29 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101752188 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2631-827X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222631827X%22">2631827X </searchLink><i>NLM ISO Abbreviation: </i>Crohns Colitis 360 <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37350775
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/crocol/otad031
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: otad031
    Titles:
      – TitleFull: Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kappelman MD
      – PersonEntity:
          Name:
            NameFull: Long MD
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Lin FC
      – PersonEntity:
          Name:
            NameFull: Weisbein L
      – PersonEntity:
          Name:
            NameFull: Chen W
      – PersonEntity:
          Name:
            NameFull: Burris J
      – PersonEntity:
          Name:
            NameFull: Dorand JE
      – PersonEntity:
          Name:
            NameFull: Parlett LE
      – PersonEntity:
          Name:
            NameFull: Fehlmann T
      – PersonEntity:
          Name:
            NameFull: Brensinger CM
      – PersonEntity:
          Name:
            NameFull: Haynes K
      – PersonEntity:
          Name:
            NameFull: Nair V
      – PersonEntity:
          Name:
            NameFull: Kaul AF
      – PersonEntity:
          Name:
            NameFull: Dobes A
      – PersonEntity:
          Name:
            NameFull: Lewis JD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 05
              Text: 2023 May 29
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2631-827X
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Crohn's & colitis 360
              Type: main
ResultId 1